Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Cash-to-Debt : 3.21 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Laboratorio Farmaceutico Erfo SpA's cash to debt ratio for the quarter that ended in Jun. 2023 was 3.21.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Laboratorio Farmaceutico Erfo SpA could pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

The historical rank and industry rank for Laboratorio Farmaceutico Erfo SpA's Cash-to-Debt or its related term are showing as below:

MIL:ERFO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.22 Med: 1.85 Max: 4.83
Current: 1.56

During the past 5 years, Laboratorio Farmaceutico Erfo SpA's highest Cash to Debt Ratio was 4.83. The lowest was 0.22. And the median was 1.85.

MIL:ERFO's Cash-to-Debt is ranked better than
67.97% of 1848 companies
in the Consumer Packaged Goods industry
Industry Median: 0.53 vs MIL:ERFO: 1.56

Laboratorio Farmaceutico Erfo SpA Cash-to-Debt Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Cash-to-Debt Chart

Laboratorio Farmaceutico Erfo SpA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

0.22

1.17

0.47

2.53

No Debt

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial			0.47	4.83	2.53	3.21	No Debt

Competitive Comparison of Laboratorio Farmaceutico Erfo SpA's Cash-to-Debt

For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorio Farmaceutico Erfo SpA's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's Cash-to-Debt falls into.

Laboratorio Farmaceutico Erfo SpA Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Laboratorio Farmaceutico Erfo SpA's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.471	/	(0.135	+	0.447)
	=	2.53

Laboratorio Farmaceutico Erfo SpA's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.735	/	(0.148	+	0.392)
	=	3.21

Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Laboratorio Farmaceutico Erfo SpA Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

RK7:Germany

Address

Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049

Website

https://www.erfo.it

Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in the formulation and production of food supplements, and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels.

Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Headlines

No Headlines